Wang Feijie, Huang Lijie, Zhang Hongmei, Jiang Hongxia, Chang Xiaoxia, Chu Yinping, Wang Zhixia, Zhang Xiaoli
Department of Urinary Surgery, Henan Provincial People's Hospital, Zhengzhou University Peoples Hospital, Zhengzhou, Henan 450003, People's Republic of China.
Nursing Department, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan 450003, People's Republic of China.
Patient Prefer Adherence. 2020 Oct 22;14:2027-2034. doi: 10.2147/PPA.S266687. eCollection 2020.
To translate and validate the DES-10 into Chinese and adapt the DES-10 among Chinese prostate cancer patients. To explore the impact of demographic data on the SDM of Chinese prostate cancer patients.
Data were collected from December 2019 to January 2020 from four hospitals among prostatic cancer patients in Henan Province, by convenience sampling method. A demographic questionnaire, DES-10, and 9-item Shared Decision Making Questionnaire (SDM-Q-9) were administered. The exploratory and confirmatory factor analysis was carried out to test the content, construct, reliability, and concurrent validity of the translated DES-10. Then, Pearson's correlation, -test, and analysis of variance were used to test the demographic difference of DES-10.
A total of 380 prostatic cancer patients completed the survey (96% response rate). The total score of DES-10 was 71.16±17.14. The Cronbach's ɑ coefficient was 0.87. Single factor structure was confirmed by exploratory factor analysis (explaining 50.14% of the variance). Model fitting indexes (RMSEA=0.07, CMIN/DF=2.92) were acceptable. The DES-10 scale showed good validity with the SDM-Q-9 as the criterion. Age, marital status, homeplace, and household monthly income could affect the shared decision-making of prostatic cancer patients.
The DES-10 was demonstrated to be a valid and reliable scale to assess the prostatic cancer patient's engagement in health care decision-making. And it is culturally appropriate for use in China. The influence of age, marital status, homeplace, and household monthly income should be considered in promoting patients' participation in shared decision-making.
将DES - 10翻译成中文并进行验证，使其适用于中国前列腺癌患者。探讨人口统计学数据对中国前列腺癌患者共同决策的影响。
于2019年12月至2020年1月，采用便利抽样法从河南省四家医院的前列腺癌患者中收集数据。发放人口统计学调查问卷、DES - 10和9项共同决策调查问卷（SDM - Q - 9）。进行探索性和验证性因素分析，以检验翻译后的DES - 10的内容、结构、信度和同时效度。然后，使用Pearson相关性分析、t检验和方差分析来检验DES - 10的人口统计学差异。
共有380例前列腺癌患者完成调查（应答率为96%）。DES - 10的总分为71.16±17.14。Cronbach's α系数为0.87。探索性因素分析证实了单因素结构（解释了50.14%的方差）。模型拟合指数（RMSEA = 0.07，CMIN/DF = 2.92）可接受。以SDM - Q - 9为标准，DES - 10量表显示出良好的效度。年龄、婚姻状况、籍贯和家庭月收入会影响前列腺癌患者的共同决策。
DES - 10被证明是评估前列腺癌患者参与医疗保健决策的有效且可靠的量表。并且它在中国具有文化适用性。在促进患者参与共同决策时，应考虑年龄、婚姻状况、籍贯和家庭月收入的影响。
